Page last updated: 2024-10-25

ciglitazone and Skin Neoplasms

ciglitazone has been researched along with Skin Neoplasms in 2 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research Excerpts

ExcerptRelevanceReference
" In this report, focusing our attention on ciglitazone, we show that ciglitazone inhibits melanoma growth by inducing apoptosis and cell-cycle arrest, whereas normal melanocytes are resistant to ciglitazone."7.75In vitro and in vivo anti-melanoma effects of ciglitazone. ( Annicotte, JS; Bahadoran, P; Ballotti, R; Bertolotto, C; Botton, T; Fajas, L; Gozzerino, G; Ortonne, JP; Puissant, A; Rocchi, S; Tartare-Deckert, S; Zamoum, T, 2009)
" In this report, focusing our attention on ciglitazone, we show that ciglitazone inhibits melanoma growth by inducing apoptosis and cell-cycle arrest, whereas normal melanocytes are resistant to ciglitazone."3.75In vitro and in vivo anti-melanoma effects of ciglitazone. ( Annicotte, JS; Bahadoran, P; Ballotti, R; Bertolotto, C; Botton, T; Fajas, L; Gozzerino, G; Ortonne, JP; Puissant, A; Rocchi, S; Tartare-Deckert, S; Zamoum, T, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botton, T1
Puissant, A1
Bahadoran, P1
Annicotte, JS1
Fajas, L1
Ortonne, JP1
Gozzerino, G1
Zamoum, T1
Tartare-Deckert, S1
Bertolotto, C1
Ballotti, R1
Rocchi, S1
Schadendorf, D1

Other Studies

2 other studies available for ciglitazone and Skin Neoplasms

ArticleYear
In vitro and in vivo anti-melanoma effects of ciglitazone.
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Re

2009
Peroxisome proliferator-activating receptors: a new way to treat melanoma?
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Humans; Melanoma; PPAR gamma; Signal Transduction; Skin Neoplasms;

2009